Benicar Articles
Daiichi Sankyo gains US FDA approval of Benicar to treat high BP in children and adolescent; names new VP medical affairs
12 February 2010
Daiichi Sankyo ups profit forecast by 13% on expected rupee gain related to Ranbaxy; files flu drug in Japan
1 February 2010
Batch of Japanese drug approvals, including for Taiho, Daiichi Sankyo and three for Novartis
20 January 2010
Ranbaxy to launch Daiichi Sankyo’s olmesartan in six African markets
23 December 2009
US mid-caps Biogen, Forest and Gilead post in-line or better-than-expected three-month results
21 October 2009
Daiichi Sankyo's Azor improves 24-hour ABP
12 May 2009
Japan stock market week to May 11, 2009
12 May 2009
Japan stock market week to Dec 15, 2008
22 December 2008
Japan stock market week to Nov 3, 2008
10 November 2008
Japan stock market week to August 4, 2008
11 August 2008
Forest's EPS falls to $0.79 in 2nd-qtr 2008
4 August 2008
Japan stock market week to June 23, 2008
30 June 2008
Benicar effective in reversing artery narrowing
23 June 2008
Mylan sued by Daiichi Sankyo over Azor patent
9 June 2008
Japan stock market week to May 19, 2008
26 May 2008
Forest takes $44M hit on ending Azor deal
19 May 2008
Japan stock market week to February 4 , 2008
14 February 2008
US physician survey finds big differences in Rx patterns between cardiologists and PCPs
4 February 2008
Japan stock market week to Jan 21, 2008
28 January 2008
Lexapro and Namenda help Forest's income for fiscal 3rd-qtr soar 21%, beating estimates
21 January 2008
Olmetec first ARB to show sclerotic regress
17 December 2007
Japan stock market week to Nov 12, 2007
19 November 2007
Forest's EPS drops 5% on Microbia charge
29 October 2007
Daiichi Sankyo and Forest finalize Azor co-promotion deal
22 October 2007
Tokyo stocks to October 8, 2007
15 October 2007
Japan stock market week to September 3, 2007
10 September 2007
Japan stock market week to August 6, 2007
13 August 2007
Forest's income for fiscal 1st qtr soars 34%
23 July 2007
Japan stock market week to July 2, 2007
9 July 2007
Japan stock market week to May 28, 2007
4 June 2007
Japan stock market week to May 21, 2007
28 May 2007
Combined bp drug Azor discussed at ASH
28 May 2007
Forest records $238M loss for fiscal 4th-qtr
7 May 2007
Japan stock market week to Feb 5, 2007
12 February 2007
Forest Labs 4th-qtr profit jumps 28%
29 January 2007
Japan stock market week to Dec 4, 2006
11 December 2006
Daiichi Sankyo files NDA for combo CV drug
4 December 2006
Japan stock market week to Nov 13, 2006
20 November 2006
Daiichi Sankyo's first-half profit jumps 35.3%
13 November 2006
Japan stock market week to Oct 30, 2006
6 November 2006
Forest Lab's 1st-qtr net revenues leap 15%
24 July 2006
Japan's pharma licks its wounds after NHI cuts
13 March 2006
Daiichi Sankyo sees increase in 2005 income
20 February 2006
Sankyo's 1st-qtr sales and earnings dip
22 August 2005
Stock Commentary - Tokyo
15 August 2005
S-P licenses Sankyo's cardio drug in Latin territories
15 August 2005
Japan stock market week to August 8
15 August 2005
Japan stock market week to June 27
4 July 2005
Forest Labs' sales hit by Celexa competition
25 April 2005
Forest disappoints, despite 17% EPS hike
24 January 2005
Generics battering Sankyo's home sales
4 October 2004
Sankyo sales down but profits leap 60%
9 August 2004
Sankyo's full-year revenues rise 4.6%
7 June 2004
Tokyo pharma stocks - week to May 24
31 May 2004
Kowa and Nikken to co-promote olmesartan medoxomil
2 February 2004
Tokyo pharma stocks - week to Jan 12
19 January 2004
Sankyo and SSK to promote olmesartan
19 January 2004
Sankyo's Benicar HCT launched in USA
22 September 2003
Tokyo pharma stocks - week to Sept 15
22 September 2003
Sankyo's Olmetec cleared in UK
8 September 2003
Lexapro offsets Celexa for Forest's 2nd-qtr
21 July 2003
Tokyo pharma stocks - week to June 16
23 June 2003
Sankyo gets FDA OK for Benicar HCT
16 June 2003
Tokyo pharma stocks - week to August 12
19 August 2002
Sankyo files new form of Benicar with FDA
12 August 2002
Tokyo pharma stocks - week to June 24
1 July 2002
Tokyo pharma stocks - week to May 27
3 June 2002
Celexa drives growth at Forest Labs
6 May 2002
Sankyo to launch Benicar in USA
6 May 2002
Tokyo pharma stocks - week to April 29
6 May 2002
Net income up 33% at Forest Labs.
21 January 2002
Forest to sell Sankyo's Benicar
13 December 2001
Showing 1-83 of 83 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
